Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus delayed primaquine after artemether-lumefantrine in children with uncomplicated malaria
ACTRN12620000855921Phase 4Suspended
- Sponsor
- The University of Western Australia
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of primaquine, artemether and lumefantrine in malaria (2 arms), sponsored by The University of Western Australia. Primary endpoints: Incidence of malaria re-infection by microscopy, Incidence of malaria re-infection by polymerase chain reaction and 1 more. Started Aug 2018; status: suspended.
02
Drugs
primaquineartemetherlumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12620000855921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000855921.